NL8900582A - Farmaceutische preparaten en nieuwe toepassingen van bepaalde piperazinecarbonzuurderivaten. - Google Patents

Farmaceutische preparaten en nieuwe toepassingen van bepaalde piperazinecarbonzuurderivaten. Download PDF

Info

Publication number
NL8900582A
NL8900582A NL8900582A NL8900582A NL8900582A NL 8900582 A NL8900582 A NL 8900582A NL 8900582 A NL8900582 A NL 8900582A NL 8900582 A NL8900582 A NL 8900582A NL 8900582 A NL8900582 A NL 8900582A
Authority
NL
Netherlands
Prior art keywords
compound
formula
pharmaceutically acceptable
treatment
hydrate
Prior art date
Application number
NL8900582A
Other languages
English (en)
Dutch (nl)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888805875A external-priority patent/GB8805875D0/en
Priority claimed from GB888819192A external-priority patent/GB8819192D0/en
Priority claimed from GB888820344A external-priority patent/GB8820344D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NL8900582A publication Critical patent/NL8900582A/nl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509Six-membered rings
    • C07F9/650952Six-membered rings having the nitrogen atoms in the positions 1 and 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8900582A 1988-03-11 1989-03-10 Farmaceutische preparaten en nieuwe toepassingen van bepaalde piperazinecarbonzuurderivaten. NL8900582A (nl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB888805875A GB8805875D0 (en) 1988-03-11 1988-03-11 Improvements in/relating to organic compounds
GB8805875 1988-03-11
GB8819192 1988-08-12
GB888819192A GB8819192D0 (en) 1988-08-12 1988-08-12 Improvements in/relating organic compounds
GB888820344A GB8820344D0 (en) 1988-08-26 1988-08-26 Improvements in/relating to organic compounds
GB8820344 1988-08-26

Publications (1)

Publication Number Publication Date
NL8900582A true NL8900582A (nl) 1989-10-02

Family

ID=27263823

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8900582A NL8900582A (nl) 1988-03-11 1989-03-10 Farmaceutische preparaten en nieuwe toepassingen van bepaalde piperazinecarbonzuurderivaten.

Country Status (15)

Country Link
US (1) US4939129A (it)
JP (1) JPH01279834A (it)
AU (1) AU618325B2 (it)
BE (1) BE1005178A3 (it)
CH (1) CH677611A5 (it)
DE (1) DE3907009A1 (it)
DK (1) DK118189A (it)
FR (1) FR2628322B1 (it)
GB (1) GB2216417B (it)
HU (1) HU202111B (it)
IT (1) IT1232818B (it)
MY (1) MY103844A (it)
NL (1) NL8900582A (it)
PT (1) PT89962B (it)
SE (1) SE470251B (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1248531A (en) * 1984-04-17 1989-01-10 Jeffrey C. Watkins 4-substituted piperazine-2-carboxylic acids

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1248531A (en) * 1984-04-17 1989-01-10 Jeffrey C. Watkins 4-substituted piperazine-2-carboxylic acids
GB8703749D0 (en) * 1987-02-18 1987-03-25 Sandoz Ltd Piperazinecarboxylic acid

Also Published As

Publication number Publication date
AU3116489A (en) 1989-09-14
HUT52383A (en) 1990-07-28
FR2628322A1 (fr) 1989-09-15
IT1232818B (it) 1992-03-05
GB2216417B (en) 1991-12-11
JPH01279834A (ja) 1989-11-10
US4939129A (en) 1990-07-03
HU202111B (en) 1991-02-28
GB2216417A (en) 1989-10-11
FR2628322B1 (fr) 1994-09-09
DE3907009A1 (de) 1989-09-21
SE470251B (sv) 1993-12-20
IT8947732A0 (it) 1989-03-10
DK118189A (da) 1989-09-12
PT89962A (pt) 1989-11-10
BE1005178A3 (fr) 1993-05-18
GB8905180D0 (en) 1989-04-19
DK118189D0 (da) 1989-03-10
SE8900834D0 (sv) 1989-03-09
MY103844A (en) 1993-09-30
PT89962B (pt) 1994-05-31
CH677611A5 (it) 1991-06-14
AU618325B2 (en) 1991-12-19
SE8900834L (sv) 1989-09-12

Similar Documents

Publication Publication Date Title
KR20010086080A (ko) N-헤테로고리 화합물의 카르복실산 및 카르복실산이소스테르
RU2680247C2 (ru) Средство, усиливающее эффект реабилитации после нервного повреждения, которое содержит производное простого алкилового эфира или его соль
HUP9600448A2 (hu) Naftilvegyületek, e vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra, intermedierjeik és alkalmazásuk
DE3709621A1 (de) Therapeutisches mittel
DE69132688D1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
JPH0136819B2 (it)
JPH10506407A (ja) 睡眠の誘導方法
GB2184653A (en) Dementia improving and therapeutic agents
FR2424253A1 (fr) Nouveaux derives de peptides analogues des enkephalines, leur procede de preparation et leur application therapeutique
ES2307671T3 (es) Compuestos de gaba n-alquilados, procedimientos para su preparacion y su uso como medicamentos.
KR20020063172A (ko) 1 - 사이클릭 아미노 - 알킬시클로헥산 화합물, 이를함유하는 약학적 조성물 및 항경련약으로서의 용도
NL8900582A (nl) Farmaceutische preparaten en nieuwe toepassingen van bepaalde piperazinecarbonzuurderivaten.
CA1314226C (en) Anti-dementia agent
WO2017129061A1 (zh) 取代桂皮酰胺衍生物在制备抗焦虑药物中的应用
DE2801478A1 (de) N hoch 2 -arylsulfonyl-l-argininamide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
IE853253L (en) Antiinflamaatory compounds
US4537907A (en) Hypnotic composition and method of inducing sleep
US2537988A (en) Sympatholytic compositions
US3629418A (en) Process for producing an anti-depressant effect with piperazine quinolines
DE69911436T2 (de) Die verwendung von r (+)- g(a)-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol zur behandlung von obstruktive schlafapnoe
EP0047990A1 (en) Hydrouracil compounds
US3337408A (en) Method of effecting analgesia
JP3681770B2 (ja) 老年性痴呆症又はアルツハイマー病治療剤
RU1045584C (ru) Производные 5-оксибензофурана, обладающие местноанестезирующим, противоаритмическим, противофибрилл торным, противосудорожным и противокаталептическим действием
US3661929A (en) Diiodomethylate 1,2 - bis(4'-pyrrolydinomethyl-1',3'-dioxolanyl-2') ethane

Legal Events

Date Code Title Description
BV The patent application has lapsed